The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis

The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis

Not required

Bibliographic Details
Main Authors: Kashaf Waqar, Anika Zainab
Format: Article
Language:English
Published: Pakistan Medical Association 2022-10-01
Series:Journal of the Pakistan Medical Association
Online Access:https://www.ojs.jpma.org.pk/index.php/public_html/article/view/6388

Similar Items

Similar Items